# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 2712 results.
Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer
Status: Not yet recruiting
Last Changed: Aug 28, 2019
First Received: Aug 28, 2019
Disease(s): Recurrent Platinum-resistant Ovarian Cancer
Intervention(s): Camrelizumab (SHR-1210), Apatinib
Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Status: Unknown status
Last Changed: Aug 25, 2016
First Received: Aug 25, 2016
Disease(s): Ovarian Cancer
Intervention(s): Cancer treatment
Locations: LAVOUE, Rennes, France
NYU Ovarian Cancer Early Detection Program Blood and Genetics
Status: Terminated
Last Changed: Jan 11, 2011
First Received: Sep 19, 2007
Disease(s): Ovarian Cancer
Locations: NYUCancer Institute Clinical Cancer Center, New York, New York, United States
Trial in Patients With Relapsed Ovarian Cancer
Status: Recruiting
Last Changed: Aug 21, 2020
First Received: Aug 30, 2017
Disease(s): Ovarian Cancer
Intervention(s): Durvalumab, Tremelilumab, MEDI 9447, MEDI 0562
Locations: VejleSygehus, Vejle, Region Syddanmark, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark
Tampere University Hospital, Tampere, Finland
Haukeland University Hospital, Bergen, Haukeland, Norway
The Norwegian Radium Hospital, Oslo, Norway
... and 1 other locations.
Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer
Status: Completed
Last Changed: Mar 02, 2010
First Received: Dec 02, 2005
Disease(s): Ovarian Cancer
Intervention(s): Exemestane
Locations: Ottawa Regional Cancer Center, Ottawa, Ontario, Canada
Weekly Topotecan Therapy in Patients With Ovarian Cancer
Status: Terminated
Last Changed: Sep 13, 2006
First Received: Sep 19, 2005
Disease(s): Ovarian Cancer
Intervention(s): Topotecan
Locations: Weill Medcial College of Cornell University, New York, New York, United States
Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Status: Completed
Last Changed: Sep 04, 2019
First Received: Sep 25, 2015
Disease(s): Ovarian Cancer
Intervention(s): Cabazitaxel, Tocotrienol
Locations: Vejle Hospital, Department of Oncology, Vejle, Denmark
Evolution of the Therapeutic Care in Ovarian Cancer From 2011
Status: Recruiting
Last Changed: Feb 20, 2019
First Received: Sep 07, 2017
Disease(s): Ovarian Cancer
Locations: Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
Institut Bergonié, Bordeaux, France
Centre François Baclesse, Caen, France
Centre Jean Perrin, Clermont-ferrand, France
Centre Georges-François Leclerc, Dijon, France
... and 16 other locations.
Phase III Trial of Stage I Ovarian Cancer After Surgery
Status: Recruiting
Last Changed: Aug 30, 2019
First Received: Aug 21, 2019
Disease(s): Epithelial Ovarian Cancer
Intervention(s): adjuvant chemotherapy
Locations: Aichi Medical University Hospital, Nagakute-shi, Aichi, Japan
Tosei General Hospital, Seto-shi, Aichi, Japan
Fujita Health University Hospital, Toyoake-shi, Aichi, Japan
Hirosaki University School of Medicine & Hospital, Hirosaki-shi, Aomori, Japan
The Jikei University School of Medicine Kashiwa Hospital, Kashiwa-shi, Chiba, Japan
... and 99 other locations.
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Status: Completed
Last Changed: Sep 12, 2018
First Received: Mar 05, 2012
Disease(s): Ovarian Cancer
Locations: University of Washington, Seattle, Washington, United States